Mindray Medical CFO, Ronald Ede, to Participate as a Panelist at the Financial Times' Global Pharmaceutical and Biotechnology Conference
More News related to MR
- Goldman Sachs Upgraded Mindray Medical (MR) to Conviction Buy
- Mindray to Hold Annual General Meeting in Hong Kong on December 15, 2009
- Mindray Medical to Exhibit at RSNA 2009 in Chicago, from November 29th to December 4th, 2009
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Mindray Medical (MR) Posts Q3 EPS of $0.38, Tops by 11c
More News related to Press Releases
- Keefe, Bruyette & Woods Downgrades First State Bancorporation (FSNM) to Market Perform
- Keefe, Bruyette & Woods Downgrades R&G Financial (RGFC) to Market Perform
SHENZHEN, China, Nov. 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that Mr. Ronald Ede, Chief Financial Officer, will participate in a panel discussion at the Financial Times' Global Pharmaceutical and Biotechnology Conference, which will be held at the Millennium Mayfair Hotel in London on November 17-18, 2009.
Mr. Ede will present as a guest panelist during the panel entitled "Exploring New Avenues for Innovation, Growth and Profitability -- The Role of Emerging Markets," which will take place on November 17, 2009 from 3:15-4:15 GMT.
To learn more about the Financial Times' Global Pharmaceutical and Biotechnology Conference, please visit http://www.ftconferences.com/pharmabio .
About Mindray
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .
For further information, please contact:
In the U.S.:
FD
Evan Smith, CFA
Tel: +1-212-850-5606
Email: evan.smith@fd.com
John Capodanno
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
Cathy Gao
Tel: +86-755-2658-2518
Email: cathy.gao@mindray.com
SOURCE Mindray Medical International Limited
Related Categories
Press ReleasesStocks Mentioned
+0.26Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
